| Chapter title |
AMPK in Cardiovascular Diseases.
|
|---|---|
| Chapter number | 8 |
| Book title |
AMP-activated Protein Kinase
|
| Published in |
EXS, November 2016
|
| DOI | 10.1007/978-3-319-43589-3_8 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-943587-9, 978-3-31-943589-3
|
| Authors |
Evangelos P. Daskalopoulos, Cécile Dufeys, Christophe Beauloye, Luc Bertrand, Sandrine Horman |
| Editors |
Mario D. Cordero, Benoit Viollet |
| Abstract |
This chapter summarizes the implication of AMP-activated protein kinase (AMPK) in the regulation of various physiological and pathological cellular events of great importance for the maintenance of cardiac function. These include the control of both metabolic and non-metabolic elements targeting the different cellular components of the cardiac tissue, i.e., cardiomyocytes, fibroblasts, and vascular cells. The description of the multifaceted action of the two AMPK catalytic isoforms, α1 and α2, emphasizes the general protective action of this protein kinase against the development of critical pathologies like myocardial ischemia, cardiac hypertrophy, diabetic cardiomyopathy, and heart failure. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 3% |
| France | 1 | 3% |
| Unknown | 31 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 18% |
| Student > Master | 4 | 12% |
| Student > Ph. D. Student | 4 | 12% |
| Student > Bachelor | 3 | 9% |
| Other | 3 | 9% |
| Other | 6 | 18% |
| Unknown | 7 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 9 | 27% |
| Medicine and Dentistry | 4 | 12% |
| Agricultural and Biological Sciences | 3 | 9% |
| Nursing and Health Professions | 3 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Other | 5 | 15% |
| Unknown | 8 | 24% |